Hatch Biofund Management

Hatch Biofund is a life sciences venture capital firm headquartered in the Philadelphia region, one of the fastest-growing biotech hubs in the world. At Hatch, we provide early-stage capital to promising life science companies, along with access to deep industry expertise and physical platforms to help them realize their missions. We put collaboration at the center of everything we do, with a core mission of delivering key support to exceptional entrepreneurs working on life-changing scientific solutions. Hatch Biofund invests exclusively in private companies developing therapeutics and vaccines for human use. We invest in all treatment modalities, from small molecules to cell and gene therapy, but are partial to capital efficiency, clear development pathways, and experimental medicines that promise to bring great value to society. We take an active role in all of our investments and leverage our partner relationships for the benefit of our portfolio companies.